Vitruvian Partners — 2015 Investments
2 investments dated 2015 · listed companies and verified rows first · show all
AlphaSense provides a financial research and market intelligence platform that combines standardized financials, consensus estimates, filings, earnings transcripts, broker research, and AI-generated answers for analyzing and benchmarking companies.
AI & Machine LearningData & InfrastructureEnterprise SoftwareFintechNew York, US
Rajmohan Neervannan(Related person at the time of the offering.)Jaakko Kokko(Related person at the time of the offering.)inRaj Neervannan(Chief Technology Officer & Co-Founder)inJaakko (Jack) Kokko(Founder)inJack Kokko(Chief Executive Officer & Founder)inKiva Kolstein(President & Chief Revenue Officer)in
Co-investorsAlkeon InnovationCapitalGCentana Growth PartnersSoftBank Vision FundTriangle Peak PartnersTribeca Venture Partners+5 more
Gelesis develops an oral superabsorbent hydrogel platform (OHS) built from naturally derived materials that works locally in the GI tract to influence satiety signals and support metabolic health.
BiotechDigital HealthHealthtechWellness & FitnessBoston, US
Yishai Zohar(Director, President, and Chief Executive Officer)inElliot Maltz(Treasurer)in
BoardJohn LaMattina(Director)Elon Boms(Director)inMeghan Fitzgerald(Director)Robert Forrester(Director)in
Co-investorsLaunchCapitalCapstar VenturesInvescoOrbiMed
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.